{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:55:22Z","timestamp":1790855722160,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-00560943"],"award-info":[{"award-number":["RS-2025-00560943"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77251-3","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:45:24Z","timestamp":1788201924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mutation-agnostic base editing of the progerin farnesylation site rescues Hutchinson-Gilford progeria syndrome phenotypes in neuromuscular organoids"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1466-2163","authenticated-orcid":false,"given":"Dong-Woo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7057-3953","authenticated-orcid":false,"given":"Eun-Ji","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom-Jin","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hyeok","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3804-1871","authenticated-orcid":false,"given":"Goo","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngyoon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7432-8994","authenticated-orcid":false,"given":"Yuna","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9478-8473","authenticated-orcid":false,"given":"Hyukjin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9277-2662","authenticated-orcid":false,"given":"Hyuk-Jin","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"77251_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-genom-082908-150150","volume":"10","author":"BS Davies","year":"2009","unstructured":"Davies, B. S., Fong, L. G., Yang, S. H., Coffinier, C. & Young, S. G. The posttranslational processing of prelamin A and disease. Annu. Rev. Genomics Hum. Genet. 10, 153\u2013174 (2009).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"77251_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature01629","volume":"423","author":"M Eriksson","year":"2003","unstructured":"Eriksson, M. et al. Recurrent de novo point mutations in lamin A cause Hutchinson\u2013Gilford progeria syndrome. Nature 423, 293\u2013298 (2003).","journal-title":"Nature"},{"key":"77251_CR3","doi-asserted-by":"publisher","unstructured":"Capell, B. C. et al. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc. Natl. Acad. Sci. USA 102, 12879\u201312884. https:\/\/doi.org\/10.1073\/pnas.0506001102 (2005).","DOI":"10.1073\/pnas.0506001102"},{"key":"77251_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-physiol-021317-121454","volume":"80","author":"MR Hamczyk","year":"2018","unstructured":"Hamczyk, M. R., Del Campo, L. & Andr\u00e9s, V. Aging in the cardiovascular system: Lessons from Hutchinson-Gilford progeria syndrome. Annu. Rev. Physiol. 80, 27\u201348 (2018).","journal-title":"Annu. Rev. Physiol."},{"key":"77251_CR5","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1111\/febs.15526","volume":"288","author":"A Marcelot","year":"2021","unstructured":"Marcelot, A. & Worman, H. J. & Zinn-Justin, S. Protein structural and mechanistic basis of progeroid laminopathies.  FEBS J. 288, 2757\u20132772 (2021).","journal-title":"FEBS J."},{"key":"77251_CR6","doi-asserted-by":"publisher","first-page":"13049","DOI":"10.1073\/pnas.192460799","volume":"99","author":"MO Bergo","year":"2002","unstructured":"Bergo, M. O. et al. Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc. Natl. Acad. Sci. 99, 13049\u201313054 (2002).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"77251_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/ng871","volume":"31","author":"AM Pend\u00e1s","year":"2002","unstructured":"Pend\u00e1s, A. M. et al. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase\u2013deficient mice. Nat. Genet. 31, 94\u201399 (2002).","journal-title":"Nat. Genet."},{"key":"77251_CR8","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1002\/ajmg.a.31346","volume":"140","author":"RC Hennekam","year":"2006","unstructured":"Hennekam, R. C. Hutchinson\u2013Gilford progeria syndrome: review of the phenotype. Am. J. Med. Genet. Part A 140, 2603\u20132624 (2006).","journal-title":"Am. J. Med. Genet. Part A"},{"key":"77251_CR9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1056\/NEJMoa0706898","volume":"358","author":"MA Merideth","year":"2008","unstructured":"Merideth, M. A. et al. Phenotype and course of Hutchinson\u2013Gilford progeria syndrome. N. Engl. J. Med. 358, 592\u2013604 (2008).","journal-title":"N. Engl. J. Med."},{"key":"77251_CR10","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nm1266","volume":"11","author":"B Liu","year":"2005","unstructured":"Liu, B. et al. Genomic instability in laminopathy-based premature aging. Nat. Med. 11, 780\u2013785 https:\/\/doi.org\/10.1038\/nm1266 (2005).","journal-title":"Nat. Med."},{"key":"77251_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13108","volume":"19","author":"A Chojnowski","year":"2020","unstructured":"Chojnowski, A. et al. Heterochromatin loss as a determinant of progerin-induced DNA damage in Hutchinson\u2013Gilford progeria. Aging Cell 19, e13108 (2020).","journal-title":"Aging Cell"},{"key":"77251_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-020-00749-y","volume":"12","author":"F K\u00f6hler","year":"2020","unstructured":"K\u00f6hler, F. et al. Epigenetic deregulation of lamina-associated domains in Hutchinson-Gilford progeria syndrome. Genome Med. 12, 1\u201316 (2020).","journal-title":"Genome Med."},{"key":"77251_CR13","doi-asserted-by":"publisher","first-page":"16666","DOI":"10.1073\/pnas.1202529109","volume":"109","author":"LB Gordon","year":"2012","unstructured":"Gordon, L. B. et al. Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson\u2013Gilford progeria syndrome. Proc. Natl. Acad. Sci. 109, 16666\u201316671 (2012).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"77251_CR14","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1001\/jama.2018.3264","volume":"319","author":"LB Gordon","year":"2018","unstructured":"Gordon, L. B. et al. Association of lonafarnib treatment vs no treatment with mortality rate in patients with Hutchinson-Gilford progeria syndrome. JAMA 319, 1687\u20131695 (2018).","journal-title":"JAMA"},{"key":"77251_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.11.003","volume":"25","author":"M Suzuki","year":"2023","unstructured":"Suzuki, M. et al. FDA approval summary for lonafarnib (Zokinvy) for the treatment of Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathies. Genet. Med. 25, 100335 (2023).","journal-title":"Genet. Med."},{"key":"77251_CR16","doi-asserted-by":"publisher","first-page":"89ra58","DOI":"10.1126\/scitranslmed.3002346","volume":"3","author":"K Cao","year":"2011","unstructured":"Cao, K. et al. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci. Transl. Med. 3, 89ra58\u201389ra58 (2011).","journal-title":"Sci. Transl. Med."},{"key":"77251_CR17","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","volume":"589","author":"LW Koblan","year":"2021","unstructured":"Koblan, L. W. et al. In vivo base editing rescues Hutchinson\u2013Gilford progeria syndrome in mice. Nature 589, 608\u2013614 (2021).","journal-title":"Nature"},{"key":"77251_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41591-021-01262-4","volume":"27","author":"M Puttaraju","year":"2021","unstructured":"Puttaraju, M. et al. Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson\u2013Gilford progeria syndrome. Nat. Med. 27, 526\u2013535 (2021).","journal-title":"Nat. Med."},{"key":"77251_CR19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41591-021-01274-0","volume":"27","author":"MR Erdos","year":"2021","unstructured":"Erdos, M. R. et al. A targeted antisense therapeutic approach for Hutchinson\u2013Gilford progeria syndrome. Nat. Med. 27, 536\u2013545 (2021).","journal-title":"Nat. Med."},{"key":"77251_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41591-019-0343-4","volume":"25","author":"E Beyret","year":"2019","unstructured":"Beyret, E. et al. Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. Nat. Med 25, 419\u2013422 https:\/\/doi.org\/10.1038\/s41591-019-0343-4 (2019).","journal-title":"Nat. Med"},{"key":"77251_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00439-023-02561-1","volume":"142","author":"JMT Hunt","year":"2023","unstructured":"Hunt, J. M. T., Samson, C. A., Rand, A. D. & Sheppard, H. M. Unintended CRISPR-Cas9 editing outcomes: a review of the detection and prevalence of structural variants generated by gene-editing in human cells. Hum. Genet. 142, 705\u2013720 (2023).","journal-title":"Hum. Genet."},{"key":"77251_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09879","volume":"472","author":"G-H Liu","year":"2011","unstructured":"Liu, G.-H. et al. Recapitulation of premature ageing with iPSCs from Hutchinson\u2013Gilford progeria syndrome. Nature 472, 221\u2013225 (2011).","journal-title":"Nature"},{"key":"77251_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.stem.2010.12.002","volume":"8","author":"J Zhang","year":"2011","unstructured":"Zhang, J. et al. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 8, 31\u201345 (2011).","journal-title":"Cell Stem Cell"},{"key":"77251_CR24","first-page":"896","volume":"6","author":"K Musunuru","year":"2013","unstructured":"Musunuru, K. Genome editing of human pluripotent stem cells to generate human cellular disease models. Dis. Models Mech. 6, 896\u2013904 (2013).","journal-title":"Dis. Models Mech."},{"key":"77251_CR25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13287-023-03394-5","volume":"14","author":"J-C Park","year":"2023","unstructured":"Park, J.-C. et al. Gene editing with \u2018pencil\u2019rather than \u2018scissors\u2019 in human pluripotent stem cells. Stem Cell Res. Ther. 14, 164 (2023).","journal-title":"Stem Cell Res. Ther."},{"key":"77251_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48111-9","volume":"15","author":"J-C Park","year":"2024","unstructured":"Park, J.-C. et al. Enhancing genome editing in hPSCs through dual inhibition of DNA damage response and repair pathways. Nat. Commun. 15, 4002 (2024).","journal-title":"Nat. Commun."},{"key":"77251_CR27","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.omtn.2023.05.015","volume":"32","author":"J-C Park","year":"2023","unstructured":"Park, J.-C. et al. MutS\u03b1 and MutS\u03b2 as size-dependent cellular determinants for prime editing in human embryonic stem cells. Mol. Ther. -Nucleic Acids 32, 914\u2013922 (2023).","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"77251_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.stem.2019.12.007","volume":"26","author":"JM Faustino Martins","year":"2020","unstructured":"Faustino Martins, J. M. et al. Self-organizing 3D Human Trunk Neuromuscular Organoids. Cell Stem Cell 26, 172\u2013186.e176 https:\/\/doi.org\/10.1016\/j.stem.2019.12.007 (2020).","journal-title":"Cell Stem Cell"},{"key":"77251_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06103-5","volume":"14","author":"X Suarez-Calvet","year":"2023","unstructured":"Suarez-Calvet, X. et al. Decoding the transcriptome of Duchenne muscular dystrophy to the single nuclei level reveals clinical-genetic correlations. Cell Death Dis. 14, 596. https:\/\/doi.org\/10.1038\/s41419-023-06103-5 (2023).","journal-title":"Cell Death Dis."},{"key":"77251_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ceb.2015.05.007","volume":"34","author":"S Gonzalo","year":"2015","unstructured":"Gonzalo, S. & Kreienkamp, R. DNA repair defects and genome instability in Hutchinson-Gilford Progeria Syndrome. Curr. Opin. Cell Biol. 34, 75\u201383 https:\/\/doi.org\/10.1016\/j.ceb.2015.05.007 (2015).","journal-title":"Curr. Opin. Cell Biol."},{"key":"77251_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-019-1558-6","volume":"15","author":"G Monnerat","year":"2019","unstructured":"Monnerat, G. et al. Metabolomic profiling suggests systemic signatures of premature aging induced by Hutchinson-Gilford progeria syndrome. Metabolomics 15, 100. https:\/\/doi.org\/10.1007\/s11306-019-1558-6 (2019).","journal-title":"Metabolomics"},{"key":"77251_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12852","volume":"18","author":"R Kreienkamp","year":"2019","unstructured":"Kreienkamp, R. et al. Doubled lifespan and patient-like pathologies in progeria mice fed high-fat diet. Aging Cell 18, e12852 (2019).","journal-title":"Aging Cell"},{"key":"77251_CR33","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.15252\/emmm.201607315","volume":"9","author":"K Harhouri","year":"2017","unstructured":"Harhouri, K. et al. MG 132-induced progerin clearance is mediated by autophagy activation and splicing regulation. EMBO Mol. Med. 9, 1294\u20131313 (2017).","journal-title":"EMBO Mol. Med."},{"key":"77251_CR34","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1172\/JCI85908","volume":"126","author":"JM Lee","year":"2016","unstructured":"Lee, J. M. et al. Modulation of LMNA splicing as a strategy to treat prelamin A diseases. J. Clin. Invest 126, 1592\u20131602 https:\/\/doi.org\/10.1172\/JCI85908 (2016).","journal-title":"J. Clin. Invest"},{"key":"77251_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/acel.12258","volume":"14","author":"I Gibbs-Seymour","year":"2015","unstructured":"Gibbs-Seymour, I., Markiewicz, E., Bekker-Jensen, S., Mailand, N. & Hutchison, C. J. Lamin A\/C-dependent interaction with 53 BP 1 promotes cellular responses to DNA damage. Aging cell 14, 162\u2013169 (2015).","journal-title":"Aging cell"},{"key":"77251_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrm3719","volume":"15","author":"S Panier","year":"2014","unstructured":"Panier, S. & Boulton, S. J. Double-strand break repair: 53BP1 comes into focus. Nat. Rev. Mol. Cell Biol. 15, 7\u201318 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"77251_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb3799","volume":"7","author":"L Etourneaud","year":"2021","unstructured":"Etourneaud, L. et al. Lamin B1 sequesters 53BP1 to control its recruitment to DNA damage. Sci. Adv. 7, eabb3799 (2021).","journal-title":"Sci. Adv."},{"key":"77251_CR38","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1111\/acel.12506","volume":"15","author":"AM Cobb","year":"2016","unstructured":"Cobb, A. M. et al. Prelamin A impairs 53 BP 1 nuclear entry by mislocalizing NUP 153 and disrupting the Ran gradient. Aging cell 15, 1039\u20131050 (2016).","journal-title":"Aging cell"},{"key":"77251_CR39","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1158\/0008-5472.CAN-09-4244","volume":"70","author":"H Cha","year":"2010","unstructured":"Cha, H. et al. Wip1 directly dephosphorylates \u03b3-H2AX and attenuates the DNA damage response. Cancer Res. 70, 4112\u20134122 (2010).","journal-title":"Cancer Res."},{"key":"77251_CR40","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.1038\/s41586-018-0380-z","volume":"560","author":"F Adikusuma","year":"2018","unstructured":"Adikusuma, F. et al. Large deletions induced by Cas9 cleavage. Nature 560, E8\u2013E9 (2018).","journal-title":"Nature"},{"key":"77251_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15464","volume":"8","author":"HY Shin","year":"2017","unstructured":"Shin, H. Y. et al. CRISPR\/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome. Nat. Commun. 8, 15464 (2017).","journal-title":"Nat. Commun."},{"key":"77251_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26097-y","volume":"12","author":"S Papathanasiou","year":"2021","unstructured":"Papathanasiou, S. et al. Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing. Nat. Commun. 12, 5855 (2021).","journal-title":"Nat. Commun."},{"key":"77251_CR43","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aba8853","volume":"368","author":"RT Walton","year":"2020","unstructured":"Walton, R. T., Christie, K. A., Whittaker, M. N. & Kleinstiver, B. P. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science 368, 290\u2013296 (2020).","journal-title":"Science"},{"key":"77251_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41477-020-00827-4","volume":"7","author":"Q Ren","year":"2021","unstructured":"Ren, Q. et al. PAM-less plant genome editing using a CRISPR\u2013SpRY toolbox. Nat. Plants 7, 25\u201333 (2021).","journal-title":"Nat. Plants"},{"key":"77251_CR45","doi-asserted-by":"publisher","first-page":"366","DOI":"10.18632\/aging.100903","volume":"8","author":"O Moiseeva","year":"2016","unstructured":"Moiseeva, O., Lopes-Paciencia, S., Huot, G., Lessard, F. & Ferbeyre, G. Permanent farnesylation of lamin A mutants linked to progeria impairs its phosphorylation at serine 22 during interphase. Aging (Albany NY) 8, 366 (2016).","journal-title":"Aging (Albany NY)"},{"key":"77251_CR46","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1126\/science.1231513","volume":"339","author":"A Quigley","year":"2013","unstructured":"Quigley, A. et al. The structural basis of ZMPSTE24-dependent laminopathies. Science 339, 1604\u20131607 https:\/\/doi.org\/10.1126\/science.1231513 (2013).","journal-title":"Science"},{"key":"77251_CR47","doi-asserted-by":"publisher","first-page":"298","DOI":"10.4161\/nucl.25751","volume":"4","author":"JM Berk","year":"2013","unstructured":"Berk, J. M., Tifft, K. E. & Wilson, K. L. The nuclear envelope LEM-domain protein emerin. Nucleus 4, 298\u2013314 (2013).","journal-title":"Nucleus"},{"key":"77251_CR48","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s43587-024-00613-3","volume":"4","author":"VR Kedlian","year":"2024","unstructured":"Kedlian, V. R. et al. Human skeletal muscle aging atlas. Nat. aging 4, 727\u2013744 (2024).","journal-title":"Nat. aging"},{"key":"77251_CR49","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s43587-024-00692-2","volume":"4","author":"X Shen","year":"2024","unstructured":"Shen, X. et al. Nonlinear dynamics of multi-omics profiles during human aging. Nat. Aging 4, 1619\u20131634 https:\/\/doi.org\/10.1038\/s43587-024-00692-2 (2024).","journal-title":"Nat. Aging"},{"key":"77251_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30800-y","volume":"13","author":"D Whisenant","year":"2022","unstructured":"Whisenant, D. et al. Transient expression of an adenine base editor corrects the Hutchinson-Gilford progeria syndrome mutation and improves the skin phenotype in mice. Nat. Commun. 13, 3068 (2022).","journal-title":"Nat. Commun."},{"key":"77251_CR51","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1016\/j.ymthe.2023.10.015","volume":"31","author":"D Duan","year":"2023","unstructured":"Duan, D. Lethal immunotoxicity in high-dose systemic AAV therapy. Mol. Ther. 31, 3123\u20133126 (2023).","journal-title":"Mol. Ther."},{"key":"77251_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15892-8","volume":"11","author":"T Jiang","year":"2020","unstructured":"Jiang, T. et al. Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope. Nat. Commun. 11, 1979 (2020).","journal-title":"Nat. Commun."},{"key":"77251_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41551-019-0357-8","volume":"4","author":"C-Q Song","year":"2020","unstructured":"Song, C.-Q. et al. Adenine base editing in an adult mouse model of tyrosinaemia. Nat. Biomed. Eng. 4, 125\u2013130 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"77251_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj6901","volume":"8","author":"JP Han","year":"2022","unstructured":"Han, J. P. et al. In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy. Sci. Adv. 8, eabj6901 (2022).","journal-title":"Sci. Adv."},{"key":"77251_CR55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature01629","volume":"423","author":"M Eriksson","year":"2003","unstructured":"Eriksson, M. et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423, 293\u2013298 https:\/\/doi.org\/10.1038\/nature01629 (2003).","journal-title":"Nature"},{"key":"77251_CR56","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1242\/jcs.03263","volume":"119","author":"Y Liu","year":"2006","unstructured":"Liu, Y., Rusinol, A., Sinensky, M., Wang, Y. & Zou, Y. DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A. J. Cell Sci. 119, 4644\u20134649 https:\/\/doi.org\/10.1242\/jcs.03263 (2006).","journal-title":"J. Cell Sci."},{"key":"77251_CR57","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1126\/science.1127168","volume":"312","author":"P Scaffidi","year":"2006","unstructured":"Scaffidi, P. & Misteli, T. Lamin A-dependent nuclear defects in human aging. Science 312, 1059\u20131063 https:\/\/doi.org\/10.1126\/science.1127168 (2006).","journal-title":"Science"},{"key":"77251_CR58","doi-asserted-by":"publisher","first-page":"8963","DOI":"10.1073\/pnas.0402943101","volume":"101","author":"RD Goldman","year":"2004","unstructured":"Goldman, R. D. et al. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson\u2013Gilford progeria syndrome. Proc. Natl. Acad. Sci. 101, 8963\u20138968 (2004).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"77251_CR59","doi-asserted-by":"publisher","first-page":"8703","DOI":"10.1073\/pnas.0602569103","volume":"103","author":"DK Shumaker","year":"2006","unstructured":"Shumaker, D. K. et al. Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging. Proc. Natl. Acad. Sci. USA 103, 8703\u20138708 https:\/\/doi.org\/10.1073\/pnas.0602569103 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77251_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2012.05.015","volume":"2","author":"X Nissan","year":"2012","unstructured":"Nissan, X. et al. Unique preservation of neural cells in Hutchinson-Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA. Cell Rep. 2, 1\u20139 (2012).","journal-title":"Cell Rep."},{"key":"77251_CR61","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.devcel.2025.10.019","volume":"61","author":"X Sun","year":"2026","unstructured":"Sun, X. et al. Vascular organoid model of Hutchinson-Gilford progeria syndrome uncovers repression of the SRF pathway in premature aging. Dev. Cell 61, 505\u2013517.e507 (2026).","journal-title":"Dev. Cell"},{"key":"77251_CR62","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1172\/JCI35876","volume":"118","author":"SH Yang","year":"2008","unstructured":"Yang, S. H., Andres, D. A., Spielmann, H. P., Young, S. G. & Fong, L. G. Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated.  J. Clin. Investig. 118, 3291\u20133300 (2008).","journal-title":"J. Clin. Investig."},{"key":"77251_CR63","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/hmg\/ddq490","volume":"20","author":"SH Yang","year":"2011","unstructured":"Yang, S. H. et al. Absence of progeria-like disease phenotypes in knock-in mice expressing a non-farnesylated version of progerin. Hum. Mol. Genet. 20, 436\u2013444 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"77251_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26714-w","volume":"12","author":"E Kenjo","year":"2021","unstructured":"Kenjo, E. et al. Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice. Nat. Commun. 12, 7101. https:\/\/doi.org\/10.1038\/s41467-021-26714-w (2021).","journal-title":"Nat. Commun."},{"key":"77251_CR65","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"77251_CR66","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1021\/jacs.2c10670","volume":"145","author":"G Tilstra","year":"2023","unstructured":"Tilstra, G. et al. Iterative design of ionizable lipids for intramuscular mRNA delivery. J. Am. Chem. Soc. 145, 2294\u20132304 https:\/\/doi.org\/10.1021\/jacs.2c10670 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"77251_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2025.102785","volume":"37","author":"J Ji","year":"2026","unstructured":"Ji, J. et al. Myomerger-derived peptide enhances skeletal muscle tropism and reduces liver transduction of lipid nanoparticles for gene delivery. Mol. Ther. Nucleic Acids 37, 102785. https:\/\/doi.org\/10.1016\/j.omtn.2025.102785 (2026).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"77251_CR68","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1038\/s12276-024-01334-8","volume":"56","author":"Y-J Kim","year":"2024","unstructured":"Kim, Y.-J. et al. Longitudinal analysis of genetic and epigenetic changes in human pluripotent stem cells in the landscape of culture-induced abnormality. Exp. Mol. Med. 56, 2409\u20132422 (2024).","journal-title":"Exp. Mol. Med."},{"key":"77251_CR69","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202209062","volume":"222","author":"Y Udi","year":"2023","unstructured":"Udi, Y. et al. A general method for quantitative fractionation of mammalian cells. J. Cell Biol. 222, e202209062 (2023).","journal-title":"J. Cell Biol."},{"key":"77251_CR70","doi-asserted-by":"publisher","unstructured":"Kwon, E.-J. Analysis code for \u201cMutation-agnostic base editing of the progerin farnesylation site rescues Hutchinson\u2013Gilford progeria syndrome phenotypes in neuromuscular organoids\u201d. Zenodo. https:\/\/doi.org\/10.5281\/zenodo.21366828 (2026).","DOI":"10.5281\/zenodo.21366828"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77251-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77251-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77251-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:02:47Z","timestamp":1790852567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77251-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77251"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77251-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7431680\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.W.K. and H.J.C. have filed a patent application related to this work. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10380"}}